Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA <20 ng/ml. These differences could be due to.

Slides:



Advertisements
Similar presentations
PSA in 2010 James L. Mohler, MD Chair, NCCN Prostate Cancer Panel Department of Urology Prostate Cancer Research Program Roswell Park Cancer Institute,
Advertisements

Radiation therapy for Early Stage Prostate Cancer John A. Kalapurakal MD Professor, Radiation Oncology Northwestern University Medical School Chicago,
Research Relevant Evidence Articles: POEM: Patient Oriented Evidence that Matters DOE: Disease Oriented Evidence Problems: Common: conditions encountered.
Clinical Effectiveness Dr. Shahram Yazdani Associate Professor of SBUMS.
What is the role of free PSA? Total PSA Range 2.5 to 4.0 ng/ml Age Range (Years) %Free PSA=60 (yrs)All Ages
Cancer Genes, Environment and Behaviour Program Professor Bruce Armstrong School of Public Health.
A novel approach to community outreach to at risk communities.
J. Jacques Carter, MD, MPH Assistant Professor of Medicine Department of Medicine Harvard Medical School Beth Israel Deaconess Medical Center Boston, Massachusetts.
Mark Lynch Clinical Lead Urology, Croydon University Hospital Consultant, St George’s Hospital
YEREVAN STATE MEDICAL UNIVERSITY INCIDENCE AND STRUCTURAL PATTERN OF CANCER IN RURAL POPULATION OF ARARAT VALLEY, ARMENIA E. Matevosyan, MPH student A.
Men’s Health Prostate Awareness. Prostate Where is it? Where is it? What is a prostate? What is a prostate? What’s the issue? What’s the issue?
Cancer Characteristics Yemi Oso Scott Asplund Anthony Pico Josh Strauss.
Movember impacts your life. 1 in 6 men will be diagnosed with prostate cancer. That is the same as 7 men in our section.
Health Disparities in cancer screening and prevention A novel approach to community outreach for at risk communities.
Combining Data Mining and Network Analysis to find Prostate Cancer Biomarkers Gabriela Jurca 1.
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
Gender & Non-Gender Specific Cancer. Quick Facts On average, 386 Canadian men will be diagnosed with prostate cancer every week. On average, 407 Canadian.
Hammer, G P; Emrich, K; Nasterlack, M; Blettner, M; Yong, M Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in.
United States Cancer Statistics 2002 Incidence and Mortality
Prostate cancer and ethnicity Luke Hounsome Public Health England.
Prostate Cancer Awareness In association with. What is Prostate Cancer?
Prostate cancer and ethnicity Luke Hounsome Public Health England ‘Hear me now’ workshop - Birmingham.
Joy Mennings and Joyce Lomans. Contents Why did we choose this subject? Why is cancer a social issue? What is cancer? Most common kinds of cancer What.
WILLIAM N. MKANTA, PH.D. WESTERN KENTUCKY UNIVERSITY Study of Prostate Cancer Screening and Mortality in Blacks and Whites.
Chris Stubbings Uro-oncology CNS
This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in.
89 PSA recurrences over median follow-up of 11.3 years
Copyright © 1998 American Medical Association. All rights reserved.
Comparison of PSA Values of Prostate Cancer Patients Before, During and After Prostate Biopsy Using Gleason Score Mehmet KILINC1, Yunus Emre GOGER1, Hasan.
Prevention of Prostate Cancer. Fact or Fiction?
2327 PROSTATE CANCER STAGE, GRADE AND POSITIVE MARGIN RATE IN MEN WITH PSA ≥ 1 ng/ml UNDERGOING RADICAL PROSTATECTOMY: POPULATION DATA ANALYSIS  Sergey.
Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.
Prostate cancer and ethnicity Luke Hounsome Public Health England
Prostate cancer and ethnicity Luke Hounsome Public Health England
Clusters of Census Tracts with High Proportions of Men with Distant-Stage Prostate Cancer Incidence in New Jersey, 1995 to 1999  Toshi Abe, MSW, CTR,
Tumor Marker Tests.
PROSTATE CANCER.
Prostate cancer and ethnicity Luke Hounsome Public Health England
سرطان الثدي Breast Cancer
HPV-Related Disease: Separating Fact From Fiction
Prostate Cancer Epidemic in Sight?
Volume 183, Issue 3, Pages (March 2010)
مناهــــج البحث العلمي
Chapter 1: Introduction
با خود مراقبتي يك برنده با شيد Be a winner with self care هفته ملی سلامت مردان ایرانی گرامی باد ) اول تا هفتم اسفند ماه 91 ) کارگاه آموزشی برنامه های.
نجاح وفشل المنشآت الصغيرة
Dose-response plots of the relation between the intake of the “Healthy” dietary pattern and prostate cancer risk in the different studies included in the.
Prostate Cancer Epidemic in Sight?
Global Burden of Urologic Cancers, 1990–2013
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Volume 65, Issue 6, Pages (June 2014)
چرا تست‌های غربالگری مهم هستند
Volume 68, Issue 4, Pages (October 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Prostate-Specific Antigen, Digital Rectal Examination, and Transrectal Ultrasonography: Their Roles in Diagnosing Early Prostate Cancer  MICHAEL R. CUPP,
MT: Male Reproductive System
Prostate cancer and ethnicity Luke Hounsome Public Health England
PSA Levels and the Probability of Prostate Cancer on Biopsy
Prostate Cancer (C61): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Figure 4 The grey zone between active
Manfred Wirth, Peter Iversen, David McLeod, William See 
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Citation: Cancer Care Ontario
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 
Quality of life: An outcomes perspective
Does PSA Testing Influence the Natural History of Prostate Cancer?
Longer testing interval may impact the outcome of a prostate biopsy following the index PSA test due to longer time for a potential tumour to grow from.
PSMA expression in pre- and posttreatment prostate carcinoma serum.
Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.
Presentation transcript:

Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA <20 ng/ml. These differences could be due to genetic influences or differences in the interaction of various hormones. Scientific evidence for the correlation between hormones, in particular androgens and the risk of prostate cancer have been equivocal. Animal model studies have shown that androgens and oestrogens play a part in mediating tumorigenesis. However, epidemiological studies based on serum samples from healthy and prostate cancer men have failed to demonstrate any clear relationship. Conclusions Serum levels of testosterone, DHT, cortisol and oestradiol may be associated with the development of prostate cancer. These hormones could be used to discriminate prostate cancer from benign causes, especially in Asian men with raised PSA. Results There were no significant difference in PSA levels between BPH (mean PSA= ng/ml) and prostate cancer (mean PSA= ng/ml) samples (p= 0.87). The serum hormone levels between CaP and BPH were not statistically significant for androstenedione, DHEA, FSH and LH. The following hormones did show statistically significant levels (α </= 0.20), in descending order :- testosterone (p=0.03); DHT (p=0.14); cortisol (p=0.14); oestrodiol (p=0.20). Logistic regression and the likelihood of prostate cancer using these parameters and PSA gave a Nagelkerke R2=0.5 Previous study have reported increasing risk of prostate cancer with increasing testosterone, decreasing sex hormone-binding globulin (SHBG), and a nonlinear, inverse association with increasing eostradiol levels. Our study showed higher cortisol levels but lower testosterone, oestradiol, DHT levels in prostate cancer patients than in BPH patients. The independent variables in our logistic regression further suggest that these variables may be important in the development of prostate cancer. Methods Sera from 2 groups of patients were collected:- treatment naïve prostate cancer (CaP) patients (n=14) and benign prostatic hyperplasia (BPH) patients (n=14). The sera were then analysed using enzyme linked immunosorbent assay ( ELISA) for testosterone, oestradiol, androstenedione, cortisol, dihydrotestosterone (DHT), dehydroepiandesterone(DHEA), follicle stimulating hormone ( FSH), luteinizing hormone (LH) and prostate specific antigen (PSA). Aim A pilot prospective case-control study to analyse the correlation between hormonal levels and prostatic diseases in Asian males. References 1. Gann PH, Hennekens CH, Ma J, et al: Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88: 1118–1126, Poster presentation sponsor No. 020 Analysis on the influence of hormones in Malaysian patients with prostatic diseases Keng Lim Ng1, Sivaprakasam Sivalingam 1, Thiha Htun1, Azad Hassan Razack1, Norman Dublin2. 1 Division of Urology, Department of Surgery, University Malaya. 2 KPJ Tawakkal Specialist Hospital, Kuala Lumpur, Malaysia. TestosteroneDHT Cortisol Oestradiol BPH cancer